Please login to the form below

Not currently logged in

Bowel Cancer UK launches research initiative

Announcement for its R&D commitment comes during Bowel Cancer Awareness Month


Bowel Cancer UK is announcing an ambitious new agenda to become the UK's leading research and campaigning charity dedicated to stopping bowel cancer.

The announcement, which comes during Bowel Cancer Awareness Month this April, will see the charity focus on improving access to early diagnosis, and best treatment and care by unlocking the reasons people die, piece by piece.

Bowel cancer is the UK's second biggest cancer killer yet it's a disease which is often overlooked and diagnosed too late. 

Every year over 41,500 people are diagnosed with bowel cancer which equates to a diagnosis every 15 minutes and around 16,000 people die of the disease, more than either breast or prostate cancer.

Bowel Cancer UK is one of two major bowel cancer charities and includes Beating Bowel Cancer - a group which does not yet conduct research.

A number of cancer charities are also conduct R&D for new drugs and surgeries, with the biggest in Britain being Cancer Research UK, which spends around £400m a year on research, as well as having a large number of R&D ties to pharma and academia.

Deborah Alsina, chief executive of Bowel Cancer UK said: “We've had enough of the misery caused by this appalling disease.  So we are re-doubling our efforts and determination to lead the change needed to stop people dying of bowel cancer.

“Our pledge today is bold: We will transform survival rates, from only one in every two people surviving over five years, to three out of four people surviving bowel cancer by 2025. That's only 10 years away so it's ambitious but we are very determined and will dedicate ourselves to making this a reality."

The charity is calling on the British public to help raise more funds to help with its research drive.

Professor Richard Wilson, Professor in cancer medicine, Queen's University Belfast and member of Bowel Cancer UK's Medical Advisory Board, is supporting the announcement, adding: "While remarkable progress has been made in recent years in bowel cancer research, we need to do much more to improve prevention and early diagnosis and provide the best treatment and care for those with all stages of bowel cancer. 

“Too many people are still suffering and dying, and it's critical that quality of life and survival rates are improved.  I applaud Bowel Cancer UK's move into pioneering research which will benefit current and future patients and help to save lives.”

Article by
Ben Adams

1st April 2015

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...